While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Cash flow is valuable, but it’s not everything - StockStory helps you identify the companies that truly put it to work. That said, here are three cash-producing companies to steer clear of and a few better alternatives.
Illinois Tool Works (ITW)
Trailing 12-Month Free Cash Flow Margin: 16.9%
Founded by Byron Smith, an investor who held over 100 patents, Illinois Tool Works (NYSE: ITW) manufactures engineered components and specialized equipment for numerous industries.
Why Does ITW Give Us Pause?
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Projected sales growth of 3.1% for the next 12 months suggests sluggish demand
- Earnings per share lagged its peers over the last two years as they only grew by 3.1% annually
Illinois Tool Works’s stock price of $250.78 implies a valuation ratio of 22x forward P/E. Read our free research report to see why you should think twice about including ITW in your portfolio.
Align Technology (ALGN)
Trailing 12-Month Free Cash Flow Margin: 16.1%
Pioneering an alternative to traditional metal braces with nearly invisible plastic aligners, Align Technology (NASDAQ: ALGN) designs and manufactures Invisalign clear aligners, iTero intraoral scanners, and dental CAD/CAM software for orthodontic and restorative treatments.
Why Is ALGN Not Exciting?
- 2.3% annual revenue growth over the last two years was slower than its healthcare peers
- Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 3.6 percentage points
- Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
At $160.53 per share, Align Technology trades at 14.2x forward P/E. Check out our free in-depth research report to learn more about why ALGN doesn’t pass our bar.
GE HealthCare (GEHC)
Trailing 12-Month Free Cash Flow Margin: 7.2%
Spun off from industrial giant General Electric in 2023 after over a century as its healthcare division, GE HealthCare (NASDAQ: GEHC) provides medical imaging equipment, patient monitoring systems, diagnostic pharmaceuticals, and AI-enabled healthcare solutions to hospitals and clinics worldwide.
Why Does GEHC Give Us Pause?
- Annual sales growth of 3.7% over the last two years lagged behind its healthcare peers as its large revenue base made it difficult to generate incremental demand
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
GE HealthCare is trading at $62.47 per share, or 12.4x forward P/E. Dive into our free research report to see why there are better opportunities than GEHC.
High-Quality Stocks for All Market Conditions
WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.
But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
